Global BGMS (Blood Glucose Monitoring System) Market Growth (Status and Outlook) 2025-2031

According to this study, the global BGMS (Blood Glucose Monitoring System) market size will reach US$ 31930 million by 2031.

A blood glucose monitoring system is a medical device or system used to measure and track blood glucose (sugar) levels in individuals, especially those with diabetes. It includes traditional self-monitoring blood glucose (SMBG) devices using test strips and glucometers, as well as advanced continuous glucose monitoring (CGM) systems that provide real-time data through wearable sensors. These systems help patients and healthcare providers manage blood sugar levels, adjust medications, and prevent complications like hypoglycemia or hyperglycemia.

The blood glucose monitoring system market is primarily driven by the global rise in diabetes prevalence, fueled by aging populations, sedentary lifestyles, and poor dietary habits. Growing awareness of the importance of glucose control, along with increased healthcare spending and government support for chronic disease management, is boosting demand for both continuous glucose monitors (CGMs) and self-monitoring blood glucose (SMBG) devices. Technological advancements such as smartphone connectivity, real-time alerts, and non-invasive sensors are further expanding the market, especially among younger and tech-savvy patients.

Despite strong demand, the market faces several challenges. High device costs, especially for CGMs and advanced digital platforms, limit access in low- and middle-income countries. In addition, user adherence and accuracy concerns—particularly with improper device usage or calibration errors—can impact clinical outcomes and patient trust. Regulatory hurdles, reimbursement issues, and the need for continuous innovation to differentiate in a competitive market also pose significant obstacles for manufacturers.

LPI (LP Information)' newest research report, the “BGMS (Blood Glucose Monitoring System) Industry Forecast” looks at past sales and reviews total world BGMS (Blood Glucose Monitoring System) sales in 2024, providing a comprehensive analysis by region and market sector of projected BGMS (Blood Glucose Monitoring System) sales for 2025 through 2031. With BGMS (Blood Glucose Monitoring System) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world BGMS (Blood Glucose Monitoring System) industry.

This Insight Report provides a comprehensive analysis of the global BGMS (Blood Glucose Monitoring System) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on BGMS (Blood Glucose Monitoring System) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global BGMS (Blood Glucose Monitoring System) market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for BGMS (Blood Glucose Monitoring System) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global BGMS (Blood Glucose Monitoring System).

This report presents a comprehensive overview, market shares, and growth opportunities of BGMS (Blood Glucose Monitoring System) market by product type, application, key players and key regions and countries.

Segmentation by Type:
Blood Glucose Test Strips
Blood Glucose Meter
CGM

Segmentation by Application:
Hospital
Household

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott
Roche
Lifescan
Ascensia
ARKRAY
Sinocare
I-SENS
Terumo
B. Braun
Acon
Yicheng
Omron
SD Biosensor
77 Elektronika
Yuwell
Osang Healthcare
AgaMatrix
Senseonics Holdings
Sinomedisite
Vivacheck
Empecs
Andon
Dexcom
Medtronic
Meiqi Medical
Medtrum Technologies
MicroTech Medical

Please note: The report will take approximately 2 business days to prepare and deliver. Show more